Bone Giant Cell Tumor

Also known as: Giant Cell Tumors of Bone / Giant Cell Tumor of Bone / Bone giant cell tumour / Giant cell tumor of the bone / Osteoclastoma / Bone giant cell tumour benign / Benign bone giant cell tumor / Benign bone giant cell tumour / Bone giant cell tumor benign / Giant cell tumor of bone (morphologic abnormality) / Giant cell tumor of bone (disorder)

DrugDrug NameDrug Description
DB06643DenosumabA RANK ligand (RANKL) inhibitor used for the management of osteoporosis in patients at high risk for bone fractures.
DrugDrug NamePhaseStatusCount
DB00399Zoledronic acid1 / 2Terminated1
DB00041Aldesleukin2Active Not Recruiting1
DB00531Cyclophosphamide2Active Not Recruiting1
DB01254Dasatinib2Completed1
DB06643Denosumab2Completed2
DB06643Denosumab2Terminated1
DB01073Fludarabine2Active Not Recruiting1
DB06186Ipilimumab2Active Not Recruiting1
DB17107Lifileucel2Active Not Recruiting1
DB09035Nivolumab2Active Not Recruiting1
DB00399Zoledronic acid2Terminated1
DB06643Denosumab3Not Yet Recruiting1
DB06643Denosumab3Unknown Status1
DB00399Zoledronic acid3Recruiting1
DB06643Denosumab4Completed1
DB06643Denosumab4Recruiting1
DB06643DenosumabNot AvailableCompleted1
DB06643DenosumabNot AvailableUnknown Status1